Enhancing azithromycin antibacterial activity by encapsulation in liposomes/liposomal-N-acetylcysteine formulations against resistant clinical strains of Escherichia coli

E. coli is an Enterobacteriaceae that could develop resistance to various antibiotics and become a multi-drug resistant (MDR) bacterium. Options for treating MDR E. coli are limited and the pipeline is somewhat dry when it comes to antibiotics for MDR bacteria, so we aimed to explore more options to...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Saudi journal of biological sciences 2020-11, Vol.27 (11), p.3065-3071
Hauptverfasser:	Aljihani, Shokran A., Alehaideb, Zeyad, Alarfaj, Reem E., Alghoribi, Majed F., Akiel, Maaged A., Alenazi, Thamer H., Al-Fahad, Ahmed J., Al Tamimi, Saad M., Albakr, Turki M., Alshehri, Abdulrahman, Alyahya, Saad M., Yassin, Alaa Eldeen B., Halwani, Majed A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Azithromycin E. coli Liposomes Multi-drug resistance bacteria N-acetylcysteine Nanoparticle Original
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!